Myeloperoxidase produces nitrating oxidants in vivo.
Journal: 2002/June - Journal of Clinical Investigation
ISSN: 0021-9738
Abstract:
Despite intense interest in pathways that generate reactive nitrogen species, the physiologically relevant mechanisms for inflammatory tissue injury remain poorly understood. One possible mediator is myeloperoxidase, a major constituent of neutrophils, monocytes, and some populations of macrophages. The enzyme uses hydrogen peroxide and nitrite to generate 3-nitrotyrosine in vitro. To determine whether myeloperoxidase produces nitrating intermediates in vivo, we used isotope dilution gas chromatography/mass spectrometry to quantify 3-nitrotyrosine in two models of peritoneal inflammation: mice infected with Klebsiella pneumoniae and mice subjected to cecal ligation and puncture. Both models developed an intense neutrophil inflammatory response, and the inflammatory fluid contained markedly elevated levels of 3-chlorotyrosine, a marker of myeloperoxidase action. In striking contrast, 3-nitrotyrosine levels rose only in the mice infected with K. pneumoniae. Levels of total nitrite and nitrate were 20-fold higher in mice injected with K. pneumoniae than in mice subjected to cecal ligation and puncture. Levels of 3-nitrotyrosine failed to increase in mice infected with K. pneumoniae that lacked functional myeloperoxidase. Our observations provide strong evidence that myeloperoxidase generates reactive nitrogen species in vivo and that it operates in this fashion only when nitrite and nitrate become available. This article was published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.
Relations:
Content
Citations
(48)
References
(48)
Clinical trials
(1)
Diseases
(2)
Drugs
(1)
Chemicals
(1)
Organisms
(3)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
J Clin Invest 109(10): 1311-1319

Myeloperoxidase produces nitrating oxidants in vivo

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA Pharmacia Corp., St. Louis, Missouri, USA Department of Anesthesiology, Department of Molecular Microbiology, and Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri, USA
Address correspondence to: Jay W. Heinecke, Division of Atherosclerosis, Nutrition and Lipid Research, Box 8046, 660 South Euclid Avenue, St. Louis, Missouri 63110, USA. Fax: (314) 362-0811; E-mail: ude.ltsuw.mi@ekcenieh.
Address correspondence to: Jay W. Heinecke, Division of Atherosclerosis, Nutrition and Lipid Research, Box 8046, 660 South Euclid Avenue, St. Louis, Missouri 63110, USA. Fax: (314) 362-0811; E-mail: ude.ltsuw.mi@ekcenieh.
Received 2002 Jan 10; Accepted 2002 Apr 5.

Abstract

Despite intense interest in pathways that generate reactive nitrogen species, the physiologically relevant mechanisms for inflammatory tissue injury remain poorly understood. One possible mediator is myeloperoxidase, a major constituent of neutrophils, monocytes, and some populations of macrophages. The enzyme uses hydrogen peroxide and nitrite to generate 3-nitrotyrosine in vitro. To determine whether myeloperoxidase produces nitrating intermediates in vivo, we used isotope dilution gas chromatography/mass spectrometry to quantify 3-nitrotyrosine in two models of peritoneal inflammation: mice infected with Klebsiella pneumoniae and mice subjected to cecal ligation and puncture. Both models developed an intense neutrophil inflammatory response, and the inflammatory fluid contained markedly elevated levels of 3-chlorotyrosine, a marker of myeloperoxidase action. In striking contrast, 3-nitrotyrosine levels rose only in the mice infected with K. pneumoniae. Levels of total nitrite and nitrate were 20-fold higher in mice injected with K. pneumoniae than in mice subjected to cecal ligation and puncture. Levels of 3-nitrotyrosine failed to increase in mice infected with K. pneumoniae that lacked functional myeloperoxidase. Our observations provide strong evidence that myeloperoxidase generates reactive nitrogen species in vivo and that it operates in this fashion only when nitrite and nitrate become available.

Abstract

Acknowledgments

We thank William Parks (Washington University) for assistance with immunohistochemical studies. Mass spectrometry experiments were performed at the Washington University School of Medicine Mass Spectrometry Resource. This work was supported by grants from the NIH (AG-121191, AG-19309, HL-64344, DK-56341, and RR-00954) and the Washington University–Pharmacia Research Program. J.P. Gaut was supported by a Cardiovascular Training Grant at Washington University School of Medicine and a grant from the Glenn/American Federation of Aging Research.

Acknowledgments

Footnotes

See the related Commentary beginning on page 1287.

Joseph P. Gaut and Jaeman Byun contributed equally to this work.

Footnotes

References

  • 1. Nathan C, Shiloh MUReactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA. 2000; 97:8841–8848.[Google Scholar]
  • 2. Moncada S, Higgs AThe L-arginine-nitric oxide pathway. N Engl J Med. 1993; 329:2002–2012.[PubMed][Google Scholar]
  • 3. Ischiropoulos HBiological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998; 356:1–11.[PubMed][Google Scholar]
  • 4. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BAApparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990; 87:1620–1624.[Google Scholar]
  • 5. Beckman JSOxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol. 1996; 9:836–844.[PubMed][Google Scholar]
  • 6. Yi D, Ingelse B, Duncan M, Smythe GQuantification of 3-nitrotyrosine in biological tissues and fluids: generating valid results by eliminating artifactual formation. J Am Soc Mass Spectrom. 2000; 11:578–586.[PubMed][Google Scholar]
  • 7. Frost MT, Halliwell B, Moore KPAnalysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J. 2000; 345:453–458.[Google Scholar]
  • 8. Halliwell B, Zhao K, Whiteman M. Nitric oxide and peroxynitrite. The ugly, uglier, and the not so good: a personal review of recent controversies. Free Radic Res. 1999; 31:651–669.[PubMed]
  • 9. Shigenaga MK, et al Inflammation and NOx-induced nitration: assay for 3-nitrotyrosine by HPLC with electrochemical detection. Proc Natl Acad Sci USA. 1997; 94:3211–3216.[Google Scholar]
  • 10. Gaut JP, Byun J, Tran HD, Heinecke JWArtifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography electrospray ionization tandem mass spectrometry. Anal Biochem. 2002; 300:252–259.[PubMed][Google Scholar]
  • 11. Pfeiffer S, Schmidt K, Mayer BDityrosine formation outcompetes tyrosine nitration at low steady-state concentrations of peroxynitrite. J Biol Chem. 2000; 275:6346–6352.[PubMed][Google Scholar]
  • 12. Reiter CD, Teng RJ, Beckman JSSuperoxide reacts with nitric oxide to nitrate tyrosine at physiological pH viaperoxynitrite. J Biol Chem. 2000; 275:32460–32466.[PubMed][Google Scholar]
  • 13. Pfeiffer S, Lass A, Schmidt K, Mayer B. Protein tyrosine nitration in cytokine-activated murine macrophages. Involvement of a peroxidase/nitrite pathway rather than peroxynitrite. J Biol Chem. 2001; 276:34051–34058.[PubMed]
  • 14. Farrell AJ, Blake DR, Palmer RMJ, Moncada SIncreased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis. 1992; 51:1219–1222.[Google Scholar]
  • 15. Klebanoff SReactive nitrogen intermediates and antimicrobial activity: role of nitrite. Free Radic Biol Med. 1993; 14:351–360.[PubMed][Google Scholar]
  • 16. Eiserich JP, Cross CE, Jones AD, Halliwell B, van der Vliet AFormation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. J Biol Chem. 1996; 271:19199–19208.[PubMed][Google Scholar]
  • 17. Eiserich JP, et al Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 1998; 391:393–397.[PubMed][Google Scholar]
  • 18. van der Vliet A, Eiserich JP, Halliwell B, Cross CEFormation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. J Biol Chem. 1997; 272:7617–7625.[PubMed][Google Scholar]
  • 19. Heinecke JW, et al Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Methods Enzymol. 1999; 300:124–144.[PubMed][Google Scholar]
  • 20. Heinecke JW, Li W, Daehnke HL, III, Goldstein JADityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem. 1993; 268:4069–4077.[PubMed][Google Scholar]
  • 21. Hope HR, et al Large-scale purification of myeloperoxidase from HL60 promyelocytic cells: characterization and comparison to human neutrophil myeloperoxidase. Protein Expr Purif. 2000; 18:269–76.[PubMed][Google Scholar]
  • 22. Brennan M-L, et al Increased athersclerosis in myeloperoxidase-deficient mice. J Clin Invest. 2001; 107:419–430.[Google Scholar]
  • 23. Gaut JP, et al Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci USA. 2001; 98:11961–11966.[Google Scholar]
  • 24. Belaaouaj A, et al Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med. 1998; 4:615–618.[PubMed][Google Scholar]
  • 25. Lauber WM, et al Mass spectrometry compatibility of two-dimensional gel protein stains. Electrophoresis. 2001; 22:906–918.[PubMed][Google Scholar]
  • 26. Hazen SL, Hsu FF, Heinecke JW. p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes. A chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase. J Biol Chem. 1996; 271:1861–1867.[PubMed]
  • 27. Byun J, Henderson JP, Mueller DM, Heinecke JW8-Nitro-2′-deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase-hydrogen peroxide-nitrite system of activated human phagocytes. Biochemistry. 1999; 38:2590–2600.[PubMed][Google Scholar]
  • 28. van Dalen CJ, Winterbourn CC, Senthilmohahn R, Kettle AJNitrite as a substrate and inhibitor of myeloperoxidase. J Biol Chem. 2000; 275:11638–11644.[PubMed][Google Scholar]
  • 29. Byun J, Mueller DM, Fabjan JS, Heinecke JWNitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide–nitrite system promotes lipid peroxidation of low density lipoprotein. FEBS Letters. 1999; 455:243–246.[PubMed][Google Scholar]
  • 30. Harrison JE, Schultz JStudies on the chlorinating activity of myeloperoxidase. J Biol Chem. 1976; 251:1371–1374.[PubMed][Google Scholar]
  • 31. Hampton M, Kettle A, Winterbourn CInside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 1998; 92:3007–3017.[PubMed][Google Scholar]
  • 32. Foote CS, Goyne TE, Lehrer RIAssessment of chlorination by human neutrophils. Nature. 1981; 301:715–716.[PubMed][Google Scholar]
  • 33. McCormick ML, et al Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lactoperoxidase, and horseradish peroxidase. J Biol Chem. 1998; 273:32030–32037.[PubMed][Google Scholar]
  • 34. Henderson JP, et al Production of brominating intermediates by myeloperoxidase: a transhalogenation pathway for generating mutagenic nucleobases during inflammation. J Biol Chem. 2001; 276:2867–2875.[PubMed][Google Scholar]
  • 35. Evans T, et al Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA. 1996; 93:9553–9558.[Google Scholar]
  • 36. Chance BThe kinetics of the complexes of peroxidase formed in the presence of chlorite or hypochlorite. Arch Biochem Biophys. 1952; 41:425–431.[PubMed][Google Scholar]
  • 37. Wu W, Chen Y, Hazen SLEosinophil peroxidase nitrates protein tyrosyl residues. J Biol Chem. 1999; 274:25933–25944.[PubMed][Google Scholar]
  • 38. Ohshima H, Friesen M, Brouet I, Bartsch HNitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol. 1990; 28:647–652.[PubMed][Google Scholar]
  • 39. Jiang Q, Hurst JKRelative chlorinating, nitrating, and oxidizing capabilities of neutrophils determined with phagocytosable probes. J Biol Chem. 1997; 272:32767–32772.[PubMed][Google Scholar]
  • 40. Sandhu JK, Privora HF, Wenckebach G, Birnboim HCNeutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model. Am J Pathol. 2000; 156:509–518.[Google Scholar]
  • 41. Klebanoff SJ, Nathan CFNitrite production by stimulated human polymorphonuclear leukocytes supplemented with azide and catalase. Biochem Biophys Res Commun. 1993; 197:192–196.[PubMed][Google Scholar]
  • 42. Yan L, Vandivier W, Suffrendini AF, Danner RLHuman polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J Immunol. 1994; 153:1825–1834.[PubMed][Google Scholar]
  • 43. Daugherty A, Dunn JL, Rateri DL, Heinecke JWMyeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994; 94:437–444.[Google Scholar]
  • 44. Leeuwenburgh C, et al Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem. 1997; 272:1433–1436.[PubMed][Google Scholar]
  • 45. Podrez EA, Schmitt D, Hoff HF, Hazen SLMyeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest. 1999; 103:1547–1560.[Google Scholar]
  • 46. Hazen SL, Heinecke JW3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 1997; 99:2075–2081.[Google Scholar]
  • 47. Tsai WC, et al Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae.Infect Immun. 1997; 65:1870–1875.[Google Scholar]
  • 48. Miyoshi S, Shinoda SMicrobial metalloproteases and pathogenesis. Microbes Infect. 2000; 2:91–98.[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.